Significant Tumor Reduction With Traditional Chinese Medicine in a Patient With Advanced Prostate Cancer: A Case Report
- PMID: 36314104
- PMCID: PMC9623378
- DOI: 10.1177/15579883221130854
Significant Tumor Reduction With Traditional Chinese Medicine in a Patient With Advanced Prostate Cancer: A Case Report
Abstract
Prostate cancer (PC) is the most common malignancy of the male genitourinary system. For patients with advanced progressive PC, the treatment strategies include second-line endocrine therapy, chemotherapy, and immunotherapy. Such therapeutic techniques are either too expensive or too toxic for some patients, and traditional Chinese medicine (TCM) has become an alternative for its low cost and low toxicity. The application of Shi-pi-san and Gui-zhi-Fu-ling-wan in PC has never been reported. We report their application on a 71-year-old male patient, who was diagnosed with PC and was undergoing endocrine therapy. He originally chose chemotherapy, and experienced acute renal failure, which required hemodialysis during hospitalization. He felt weak and opted for Chinese herbal medicine treatment. After treatment with Shi-pi-san and Gui-zhi-Fu-ling-wan, the patient's tumor and other symptoms were significantly reduced, and he reported feeling "refreshed." This case indicates that TCM treatment has unique advantages and is more tolerable than endocrine therapy and chemotherapy. Considering that the patient was undergoing hemodialysis treatment and using low-molecular-weight heparin (LMWH) to prevent blood coagulation while taking TCM, whether LMWH has a synergistic anticancer effect remains to be explored.
Keywords: Gui-zhi-Fu-ling-wan; Shi-pi-san; case report; prostate cancer; traditional Chinese medicine.
Conflict of interest statement
The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures




Similar articles
-
Prescription patterns of Chinese herbal products for post-surgery colon cancer patients in Taiwan.J Ethnopharmacol. 2014 Aug 8;155(1):702-8. doi: 10.1016/j.jep.2014.06.012. Epub 2014 Jun 16. J Ethnopharmacol. 2014. PMID: 24945402
-
Comparing the effects of estrogen and an herbal medicine on peripheral blood flow in post-menopausal women with hot flashes: hormone replacement therapy and gui-zhi-fu-ling-wan, a Kampo medicine.Am J Chin Med. 2005;33(2):259-67. doi: 10.1142/S0192415X05002813. Am J Chin Med. 2005. PMID: 15974485 Clinical Trial.
-
Prescription patterns of Chinese herbal products for patients with uterine fibroid in Taiwan: A nationwide population-based study.J Ethnopharmacol. 2015 Aug 2;171:223-30. doi: 10.1016/j.jep.2015.05.038. Epub 2015 Jun 4. J Ethnopharmacol. 2015. PMID: 26051833
-
Traditional Chinese Medicine Induced Liver Injury.J Clin Transl Hepatol. 2014 Jun;2(2):80-94. doi: 10.14218/JCTH.2014.00003. Epub 2014 Jun 15. J Clin Transl Hepatol. 2014. PMID: 26357619 Free PMC article. Review.
-
Toxicity of traditional Chinese medicine herbal and mineral products.Adv Pharmacol. 2020;87:301-346. doi: 10.1016/bs.apha.2019.08.001. Epub 2019 Oct 18. Adv Pharmacol. 2020. PMID: 32089237 Review.
References
-
- Altinbas M., Coskun H. S., Er O., Ozkan M., Eser B., Unal A., et al. (2004). A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer. Journal of Thrombosis & Haemostasis, 2, 1266–1271. - PubMed
-
- Ayeka P. A., Bian Y. H., Mwitari P. G., Chu X., Zhang Y., Uzayisenga R., Otachi E. O. (2016). Immunomodulatory and anticancer potential of Gan cao (Glycyrrhiza uralensis Fisch.) polysaccharides by CT-26 colon carcinoma cell growth inhibition and cytokine IL-7 upregulation in vitro. BMC Complementary & Alternative Medicine, 16, 206. - PMC - PubMed
-
- Basu A., Haldar S. (2008). Dietary isothiocyanate mediated apoptosis of human cancer cells is associated with Bcl-xL phosphorylation. International Journal of Oncology, 33(4), 657–663. - PubMed
-
- Bobek V., Kovařík J. (2004). Antitumor and antimetastatic effect of warfarin and heparins. Biomedicine & Pharmacotherapy, 58(4), 213–219. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous